Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNS

Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNS

Primary T-cell CNS lymphoma is a rare and aggressive malignancy. High-dose methotrexate (MTX) based chemotherapy regimens are used as standard first-line treatment, followed by consolidative strategies to improve the duration of response. Although MTX-based therapy has been shown to be efficacious,...

Full description

Bibliographic Details
Main Authors: Andy Liu, Huda Alalami, Xuemo Fan, Chirag Patil, Jaya M Gill, Santosh Kesari, Jethro Hu
Format: Article
Language:English
Published: Taylor & Francis Group 2023-09-01
Series:CNS Oncology
Subjects:
case report
PCNSL
pemetrexed
T cell
T-cell lymphoma
Online Access:https://www.futuremedicine.com/doi/10.2217/cns-2022-0021

Similar Items

Similar Items